New calculator predicts risk of early recurrence in patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality worldwide, with China accounting for over half of the global annual cases and deaths.

MSU scientists unveil a potential game-changer in the fight against glioblastoma

A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of

February 6, 2024

Opinion | I Can’t Guarantee Your Next Round of Chemo

Teplinsky is a breast and gynecologic medical oncologist. “We are running low on cisplatin.” “The e-mail came. We are out of carboplatin.” “How do I

July 6, 2023

Sensi.AI Launches AI-Powered Care Copilot in Canada

What You Should Know: – Sensi.AI, the leader in care intelligence, announced a partnership with Right at Home Canada, one of the world’s foremost providers of

February 28, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.